or
forgot password

Amino Acid Transport Imaging of Breast Carcinoma Via Anti-3-[18F]FACBC PET-CT: A Pilot Study


Phase 0
18 Years
85 Years
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Amino Acid Transport Imaging of Breast Carcinoma Via Anti-3-[18F]FACBC PET-CT: A Pilot Study


Inclusion Criteria:



1. Patients must be 18 years of age or older.

2. Patients will have a breast mass and/or lymph nodes naïve to therapy about to undergo
biopsy or post-biopsy pre-therapy. Patients with known or suspected recurrent disease
will be eligible for this protocol.

3. Ability to lie still for PET scanning

4. Patients must be able to provide written informed consent

Exclusion Criteria:

1. Age less than 18.

2. Inability to lie still for PET scanning.

3. Cannot provide written informed consent.

4. Current therapy for breast carcinoma.

5. Positive serum or urine pregnancy test within 24 hours of study.

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Presence of FACBC radiotracer in breast carcinoma on FACBC PET scan

Outcome Time Frame:

Outcomes will be assessed at the end of one year.

Safety Issue:

Yes

Authority:

United States: Food and Drug Administration

Study ID:

FACBCBr

NCT ID:

NCT01659645

Start Date:

August 2012

Completion Date:

Related Keywords:

  • Breast Cancer
  • Breast Neoplasms

Name

Location

Emory University Atlanta, Georgia  30322